Antibody testing: understanding COVID-19 immunity and response to vaccinations

Learn how the flexibility of rapid tests help with proving vaccine efficacy when needing to test the widest cohort. Read More
The COVID-19 pandemic has seen the global mobilisation of diagnostics: predominantly rapid tests and lab-based molecular tests. The deployment of laboratory molecular testing has highlighted the barriers in reaching the widest patient cohort and delivering fast test results. Abingdon Health spoke with… Read More
The importance of processing data from lateral flow rapid tests while recording the exact GPS position Read More
COVID-19 increased the need to deploy novel diagnostics in great numbers and quickly. Companies mobilized capabilities to ensure those in most need have access to testing solutions. Everyone has heard of PCR’s (Polymerase Chain Reaction) and their ability to copy and amplify specific nucleic acid sequences. This revolutionized molecular testing… Read More
Learn the crucial reasons why scale-up should be considered early in the assay development process. Read More
Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak. Read More
Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering. Read More
Learn about some of the technical considerations for selecting antibodies during lateral flow assay development. Read More
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project. Read More
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market. Read More